Insights from 2023 ASH Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitamab, Rituximab, & Acalabrutinib Alone and With Combination Chemo for 1L DLBCL"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jason Westin
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jason Westin
Comments 0
Login to view comments.
Click here to Login
